ReviewJournal of experimental orthopaedics2026
Association of tranexamic acid use and autologous predonation with blood loss and transfusion outcomes after periacetabular osteotomy: An arm-based multilevel meta analysis.
Review in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the association between tranexamic acid (TXA) use, autologous predonation and perioperative blood management outcomes after periacetabular osteotomy (PAO) using an arm-based multilevel meta-analytic framework. Methods: A systematic search of PubMed, Embase, Epistemonikos and the Cochrane Central Register of Controlled Trials (CENTRAL) was performed up to 30 March 2026. Prospective and retrospective primary clinical studies reporting perioperative blood management outcomes after PAO were included. Comparisons between TXA and non-TXA arms, as well as predonation and no-predonation arms, were performed using arm-based multilevel random-effects meta-analysis. Results: Forty-three studies comprising 4315 patients and 4674 hips were included. TXA use was associated with lower estimated blood loss (mean difference [MD] -185.6 mL, 95% confidence interval [CI]: -341.1 to -30.1), lower intraoperative blood loss (MD: -299.4 mL, 95% CI: -392.2 to -206.6), fewer transfused units (MD: -0.67, 95% CI: -0.89 to -0.45) and a lower transfusion rate (OR: 0.14, 95% CI: 0.056-0.338). No significant differences were observed for haemoglobin-related outcomes, complications, reoperations or conversion to total hip arthroplasty. Autologous predonation was not associated with reductions in blood loss or transfusion-related outcomes and was associated with lower postoperative haemoglobin levels (MD: -5.5 g/L, 95% CI: -9.0 to -1.9). The certainty of evidence ranged from low to very low, and substantial heterogeneity was observed across most analyses. Conclusion: TXA use was associated with reduced blood loss and transfusion requirements after PAO, whereas autologous predonation was not associated with measurable clinical benefit. Given the substantial heterogeneity and low certainty of evidence, these findings should be interpreted cautiously. Level of Evidence: Level III, systematic review and meta-analysis of predominantly retrospective cohort studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.